The Campaign for Sustainable Rx Pricing (CSRxP), of which the AHA is a founding member, today launched new television and digital advertising encouraging policymakers to hold brand name drug companies accountable. The ads, part of CSRxP’s Promises Made campaign, will target Washington, D.C. and 10 states, including Alaska, Arizona, Colorado, Delaware, Georgia, New Hampshire, New Jersey and West Virginia.

“Policymakers in Washington promised the American people action to lower prescription drug prices and hold Big Pharma accountable,” said CSRxP Executive Director Lauren Aronson. “The millions of Americans who cannot afford their medications as a result of Big Pharma’s egregious price hikes, that continued during the pandemic, are counting on promises made to become promises kept.”

 

Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The Department of Labor Oct. 29 finalized a rule designed to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to…
Headline
The Centers for Medicare & Medicaid Services Sept. 30 finalized its Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model. The…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 18 that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in its…